Linking pages
- Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% | Ars Technica http://arstechnica.com/science/2016/08/rage-mounts-against-pharma-corp-that-jacked-cost-of-life-saving-epipen-by-400/ 197 comments
- Mylan CEO “frustrated” by own price gouging but doesn’t lower EpiPen price | Ars Technica http://arstechnica.co.uk/science/2016/08/mylan-ceo-frustrated-by-own-price-gouging-but-doesnt-lower-epipen-price/ 40 comments
Related searches:
Search whole site: site:www.statnews.com
Search title: Controversial CEO in the hot seat over EpiPen price hikes
See how to search.